Genetic therapies and xenotransplantation

Bibliography

• EVANS RW, ORIANS CE, ASCHER NL: The potential supply of organ donors: an assessment of the efficiency of organ procurement efforts in the United States. JAMA (1992) 267:239–246.
   PubMed Web of Science ®Google Scholar
• STARZL TE, FUNG J, TZAKIS A et al.: Baboon-to-human liver transplantation. Lancet (1993) 341:65–71.
   PubMed Web of Science ®Google Scholar
• LOGAN JS, MARTIN MJ: Transgenic swine as a recombi-nant production system for human hemoglobin. Methods Enzymol. (1994) 231:435–445.
   PubMed Web of Science ®Google Scholar
• SPRINGER M, CHEN A, KRAFT P, M. B, HM B: VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Molecular Cell (1998) 2:549–558.
   PubMed Web of Science ®Google Scholar
• PLATT JL: Hyperacute Xenograft Rejection. RG Landes (Ed.), Medical Intelligence Unit, New York (1995).
   Google Scholar
• GALILI U: Interaction of the natural anti-Gal antibody with a-galactosyl epitopes: a major obstacle for xenotransplantation in humans. ImmunoL Today (1993) 14:480–482.
   PubMedGoogle Scholar
• SAADI S, IHRCKE NS, PLATT JL: Pathophysiology of xenograft rejection. In: Principles of immunomodulatoly drug development in transplantation and autoimmunity, 1st edition Lieberman R, Morris R, (Eds.), Raven Press, New York, (1996):31–45.
   Google Scholar
• PLATT JL, VERCELLOTTI GM, DALMASSO AP, MATAS AJ, BOLMAN RM, NAJARIAN JS et al.: Transplantation of discordant xenografts: a review of progress. Immunol. Today (1990) 11:450–456.
   PubMedGoogle Scholar
• ••This paper provides a blueprint for analysing the causes ofxenograft injury, and the first proposal for genetic engineering of animals to be used as the source of xenografts.
   Google Scholar
• LIN SS, KOOYMAN DL, DANIELS LJ, DAGGETT CW, PARKER W, LAWSON JH et al.: The role of natural anti-Gala1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transplant Immunology (1997) 5:212–218.
   PubMed Web of Science ®Google Scholar
• LIN SS, WEIDNER BC, BYRNE GW et al.: The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J. Clin. Invest. (1998) 101:1745–1756.
   PubMed Web of Science ®Google Scholar
• ••This paper demonstrates that antibodies cause acutevascular rejection, a major hurdle to xenotransplantation of organs, opening the door to the development of therapies for addressing this problem.
   Google Scholar
• PLATT JL: Complement Inhibitors. In: Inflammation:Basic Principles and Clinical Correlates. Third ed. Gallin JI, Snyderman R, Fearon DT, Haynes BF, Nathan C, (Eds.), Lippincott-Raven, Philadelphia, USA (1999).
   Google Scholar
• LEVENTHAL JR, DALMASSO AP, CROMWELL JW et al.:Prolongation of cardiac xenograft survival by depletion of complement. Transplantation (1993) 55: 857–866.
   PubMed Web of Science ®Google Scholar
• PRUITT SK, KIRK AD, BOLLINGER RR, MARSH JR HC,COLLINS BH, LEVIN JL et al.: The effect of soluble complement receptor Type 1 on hyperacute rejection of porcine xenografts. Transplantation (1994) 57:363–370.
   Google Scholar
• KROSHUS TJ, ROLLINS SA, DALMASSO AP, ELLIOTT EA,MATIS LA, SQUINTO SP et al.: Complement inhibition with an anti-05 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation. Transplantation (1995) 60:1194–1202.
   Google Scholar
• MAGEE JC, COLLINS BH, HARLAND RC, LINDMAN BJ, BOLLINGER RR, FRANK MM et al.: Immunoglobulin prevents complement mediated hyperacute rejection in swine-to-primate xenotransplantation. J. Clin. Invest. (1995) 96:2404–2412.
   PubMed Web of Science ®Google Scholar
• COZZI E, WHITE DJG: The generation of transgenic pigs as potential organ donors for humans. Nature Med. (1995) 1:964–966.
   PubMed Web of Science ®Google Scholar
• PLATT JL, LOGAN JS: Use of transgenic animals in xenotransplantation. Transplant Rev. (1996) 10:69–77.
   Google Scholar
• MCCURRY KR, KOOYMAN DL, ALVARADO CG, COTTERELL AH, MARTIN MJ, LOGAN JS et al.: Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med. (1995) 1:423–427.
   PubMed Web of Science ®Google Scholar
• ••This paper reports the first use of transgenic animals as asource of experimental xenografts.
   Google Scholar
• BYRNE GW, MCCURRY KR, MARTIN MJ, MCCLELLAN SM,PLATT JL, LOGAN JS: Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation (1997) 63:149–155.
   PubMed Web of Science ®Google Scholar
• COZZI E, YANNOUTSOS N, LANGFORD GA, PINO-CHAVEZ G, WALLWORK J, WHITE DJG: Effect of transgenic expression of human decay-accelerating factor on the inhibition of hyperacute rejection of pig organs. In: Xenotransplantation: the transplantation of organs and tissues between species. 2nd ed. Cooper DKC, Kemp E, Platt JL, White DJG, (Eds.), Springer, Berlin, Germany (1997):665–682.
   Google Scholar
• ••This paper reports an extraordinary improvement in thesurvival of experimental xenografts achieved by the use of transgenic animals expressing human complement regulatory proteins and aggressive therapy of the recipient.
   Google Scholar
• GELLER RL, RUBINSTEIN P, PLATT JL: Variation in expression of porcine xenogeneic antigens. Transplantation (1994) 58:272–277.
   PubMed Web of Science ®Google Scholar
• SANDRIN MS, FODOR WL, MOUHTOURIS E et al.: Enzymatic remodelling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Med. (1995) 1:1261–1267.
   PubMed Web of Science ®Google Scholar
• ••This paper reports the first genetic strategy for modifying theexpression of antigens of importance in xenotransplant rejection.
   Google Scholar
• COWAN P, CHEN C, SHINKEL T, FISICARO N, SALVARIS E, AMINIAN A et al.: Knock out of alphal, 3-galactosyltransferase or expression of alphal,2-fucosyltransferase further protects CD55-and CD59-expressing mouse hearts in an ex vivo model of xenograft rejection. Transplantation (1998) 65: 1599-1604.
   Google Scholar
• PARKER W, SAADI S, UN SS, HOLZKNECHT ZE, BUSTOS M, PLATT JL: Transplantation of discordant xenografts: a challenge revisited. Immunol. Today (1996) 17:373–378.
   PubMedGoogle Scholar
• PLATT JL, UN SS, MCGREGOR CGA: Acute vascular rejection. Xenotransplantation (1998) 5:169–175.
   PubMed Web of Science ®Google Scholar
• MCCURRY KR, PARKER W, COTTERELL AH, WEIDNER BC, UN SS, DANIELS LJ et al.: Humoral responses in pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Hum. Immunol. (1997) 58:91–105.
   PubMed Web of Science ®Google Scholar
• YANG Y-G, DEGOMA E, OHDAN H, BRACY JL, XU Y, IACOMINI J et al.: Tolerization of anti-Gala 1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J. Exp. Med. (1998) 187:1335–1342.
   PubMed Web of Science ®Google Scholar
• BRACY JL, SACHS DH, IACOMINI J: Inhibition of xenore-active natural antibody production by retroviral gene therapy. Science (1998) 281:1845–1847.
   PubMed Web of Science ®Google Scholar
• ••This paper reports the achieving of tolerance as an approachto inhibiting the production of antibodies that mediate xenotransplant rejection.
   Google Scholar
• BANNETT AD, MCALACK RF, MORRIS M, CHOPEK M, PLATT JL: ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplant. Transpl. Proc. (1989) 21:783–785.
   PubMed Web of Science ®Google Scholar
• AUCHINCLOSS JR. H, SACHS DH: Xenogeneic transplan-tation. Ann. Rev. Immunol (1998) 16:433–470.
   PubMed Web of Science ®Google Scholar
• AKHTER SA, SKAER CA, KYPSON AP, MCDONALD PH, PEPPEL KC, GLOWER DD et al.: Restoration of 8-adrene-rgic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc. Natl. Acad. Sci. USA (1997) 94:12100–12105.
   PubMed Web of Science ®Google Scholar
• LAWSON JH, PLATT JL: Molecular barriers to xenotrans-plantation. Transplantation (1996) 62:303–310.
   PubMed Web of Science ®Google Scholar
• CHAPMAN LE, FOLKS TM, SALOMON DR, PATTERSON AP,EGGERMAN TE, NOGUCHI PD: Xenotransplantation and xenogeneic infections. New Engl. J. Med. (1995) 333:1498–1501.
   PubMed Web of Science ®Google Scholar
• PATIENCE C, TAKEUCHI Y, WEISS RA: Infection of human cells by an endogenous retrovirus of pigs. Nature Merl.(1997) 3:282–286.
   PubMed Web of Science ®Google Scholar
• ••This paper reports that the endogenous retrovirus of pigscan be transmitted to human cells in culture, raising concern that infection could pose a risk to public health.
   Google Scholar
• PATIENCE C, PATTON GS, TAKEUCHI Y, WEISS RA, MCCLURE MO, RYDBERG L et al.: No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet (1998) 352:699–701.
   PubMed Web of Science ®Google Scholar
• ••This paper reports that patients who received xenografts donot appear to be infected by the endogenous retrovirus, thus addressing some concerns relating to public health.
   Google Scholar
• DEACON T, SCHUMACHER J, DINSMORE J, THOMAS C, PALMER P, KOTT S et al.: Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nature Merl. (1997) 3:350–353.
   PubMed Web of Science ®Google Scholar
• HOLZKNECHT ZE, PLATT JL: Identification of porcineendothelial cell membrane antigens recognized by human xenoreactive antibodies. J. Immunol. (1995) 154:4565–4575.
   PubMed Web of Science ®Google Scholar
• SAADI S, HOLZKNECHT RA, PATTE CP, STERN DM, PLATTJL: Complement-mediated regulation of tissue factor activity in endothelium. J. Exp. Merl. (1 9 9 5) 182:1807-1814.
   Google Scholar
• BUSTOS M, COFFMAN TM, SAADI S, PLATT JL: Modula-tion of eicosanoid metabolism in endothelial cells in a xenograft model: role of cyclooxygenase-2. J. Clin. Invest. (1997) 100:1150–1158.
   PubMed Web of Science ®Google Scholar
• PLATT JL, VERCELLOTTI GM, LINDMAN BJ, OEGEMA TR, JR., BACH FH, DALMASSO AP: Release of heparan sulfate from endothelial cells: Implications for the pathogenesis of hyperacute rejection. J. Exp. Merl. (1990) 171:1363–1368.
   Google Scholar
• BLAKELY ML, VAN DER WERF WJ, BERNDT MC, DALMASSO AP, BACH FH, HANCOCK WW: Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation (1994) 58:1059–1066.
   PubMed Web of Science ®Google Scholar
• MALYGUINE AM, SAADI S, HOLZKNECHT RA, PATTE CR, SUD N, PLATT JL et al.: Induction of procoagulant function in porcine endothelial cells by human NK cells. J. Immunol (1997) 159:4659–4664.
   PubMed Web of Science ®Google Scholar
• ZEHR KJ, HERSKOWITZ A, LEE PC, KUMAR P, GILLINOV AM, BAUMGARTNER WA: Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species. Transplantation (1994) 57:900–906.
   PubMed Web of Science ®Google Scholar
• BUSTOS M, PLATT JL: Platelet-endothelial cell interac-tions in a xenograft model. Trans. Proc. (1997) 29:886.
   PubMed Web of Science ®Google Scholar
• BUSTOS M, SAADI S, PLATT JL: Platelet-mediated activa-tion of endothelial cells: implications for the pathogenesis of transplant rejection. (1 9 9 7) (Submitted).
   Google Scholar
• LAWSON JH, DANIELS L, PLATT JL: The evaluation ofthrombomodulin activity in porcine to human xenotransplantation. Trans. Proc. (1997) 29:884–885.
   PubMed Web of Science ®Google Scholar
• BACH FH, WINKLER H, FERRAN C, HANCOCK WW, ROBSON SC: Delayed xenograft rejection. Immunol. Today (1996) 17:379-384. Jeffrey L Platt
   Google Scholar